tiprankstipranks
Trending News
More News >

Argent Biopharma Announces Cessation of Securities

Story Highlights
Argent Biopharma Announces Cessation of Securities

Don’t Miss TipRanks’ Half-Year Sale

Argent Biopharma ( (AU:RGT) ) has issued an announcement.

Argent Biopharma Limited announced the cessation of 50,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of June 30, 2025. This cessation may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.

More about Argent Biopharma

Argent Biopharma Limited operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is listed on the Australian Securities Exchange under the code RGT.

Average Trading Volume: 49,032

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$5.07M

Find detailed analytics on RGT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1